Oruka Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oruka Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Oruka Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $9M, a 5745% increase year-over-year.
  • Oruka Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $9.37M, a 1309% increase year-over-year.
  • Oruka Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $686K, a 23.4% increase from 2022.
  • Oruka Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $556K, a 11.9% increase from 2021.
  • Oruka Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $497K, a 1056% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.37M $9M +$8.85M +5745% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $521K $112K -$75K -40.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $596K $114K -$90K -44.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $686K $141K +$21K +17.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-01
Q3 2023 $665K $154K +$57K +58.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-18
Q2 2023 $608K $187K +$15K +8.72% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $593K $204K +$37K +22.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 $556K $120K +$1K +0.84% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-01
Q3 2022 $555K $97K -$7K -6.73% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 $562K $172K +$39K +29.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-21
Q1 2022 $523K $167K +$26K +18.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-24
Q4 2021 $497K $119K +$101K +561% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-24
Q3 2021 $396K $104K +$99K +1980% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $297K $133K +$129K +3225% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $168K $141K +$125K +781% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q4 2020 $43K $18K -$9K -33.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $52K $5K -$24K -82.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $76K $4K -$41K -91.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $117K $16K -$34K -68% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $151K $27K -$31K -53.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $182K $29K -$29K -50% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $211K $45K -$15K -25% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $226K $50K -$47K -48.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $273K $58K -$61K -51.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 $334K $58K -$61K -51.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $395K $60K -$59K -49.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $454K $97K -$4K -3.96% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $458K $119K +$148K Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 $310K $119K -$148K -55.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $458K $119K -$64K -35% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $522K $101K -$54K -34.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $576K -$29K -$174K -120% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-22
Q3 2016 $750K $267K +$118K +79.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $632K $183K +$8K +4.57% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 $624K $155K +$25K +19.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $599K $145K -$11K -7.05% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-21
Q3 2015 $610K $149K -$12K -7.45% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $622K $175K +$3K +1.74% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $619K $130K -$28K -17.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 $647K $156K -$2K -1.27% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-17
Q3 2014 $649K $161K +$112K +229% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $537K $172K +$138K +406% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 $399K $158K +$116K +276% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $283K $158K +$95K +151% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-19
Q3 2013 $188K $49K -$25K -33.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $213K $34K -$44K -56.4% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $257K $42K -$49K -53.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $306K $63K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 $74K -$5K -6.33% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $78K +$3K +4% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 $91K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q3 2011 $79K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $75K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.